Oncolytics Biotech Inc (ONCY.OQ)

ONCY.OQ on NASDAQ Stock Exchange Capital Market

0.59USD
26 Dec 2014
Price Change (% chg)

$0.10 (+19.46%)
Prev Close
$0.49
Open
$0.48
Day's High
$0.61
Day's Low
$0.48
Volume
93,503
Avg. Vol
119,583
52-wk High
$2.07
52-wk Low
$0.40

ONCY.OQ

Chart for ONCY.OQ

About

Oncolytics Biotech Inc. (Oncolytics) is a development-stage company. The Company is focused on its research and development of REOLYSIN, which is its cancer therapeutic. REOLYSIN is developed from the reovirus. This virus has been demonstrated in tumour cells bearing an activated Ras pathway. Oncolytics is directing a clinical... (more)

Overall

Beta: 2.10
Market Cap (Mil.): $42.65
Shares Outstanding (Mil.): 91.81
Dividend: --
Yield (%): --

Financials

  ONCY.OQ Industry Sector
P/E (TTM): -- 159.35 38.84
EPS (TTM): -0.21 -- --
ROI: -97.29 -0.82 18.26
ROE: -97.29 -1.98 19.12
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks